AMBRA1 and Parkinson disease: It is interesting to note how a defective activity of AMBRA1 has been demonstrated beyond AMD in the course of CNS degenerative disorders such as Parkinson’s disease (PD) and Alzheimer’s disease (AD), [31,140,141,142].